Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast CancerMariaelena Pierobon, Emanuel F. Petricoin, Corinne Ramos et al.|Clinical Cancer Research|2017Cited by 97
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancerGayle Jameson, Nicholas J. Robert, Emanuel F. Petricoin et al.|Breast Cancer Research and Treatment|2014Cited by 82
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicineElisa Baldelli, Mariaelena Pierobon, Chamodya T Ruhunusiri et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 15
Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trialMariaelena Pierobon, Stephen P. Anthony, Nicholas J. Robert et al.|Molecular Oncology|2021Cited by 14
Multi-omic profiling of metastatic lesions to guide treatment selection: The Side Out 2 trial experience.Mariaelena Pierobon, Stephen P. Anthony, Nicholas J. Robert et al.|Journal of Clinical Oncology|2018Cited by 4